Comparison of bone marrow-vs. adipose tissue-derived mesenchymal stem cells for attenuating liver fibrosis

Mesenchymal stem cell (MSC) therapy has emerged as a potential novel method of treating liver fibrosis. To date, bone marrow-derived MSCs (BM-MSCs) and adipose tissue-derived MSCs (AD-MSCs) have not been analyzed with respect to their ability to combat liver fibrosis. The present study aimed to comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Tianpao, Chen, Jingfeng, Zhi, Shaoce, Zhang, Qiyu, Chen, Gang, Yu, Fuxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740792/
https://www.ncbi.nlm.nih.gov/pubmed/29285145
http://dx.doi.org/10.3892/etm.2017.5333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740792/
https://www.ncbi.nlm.nih.gov/pubmed/29285145
http://dx.doi.org/10.3892/etm.2017.5333

Ejemplares similares